Gene · 117189
Papers1,950
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,950
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease. | Int J Mol Sci | 2026 | 41751844 | PubTator, text mining | PubMed |
| Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients by Multiple TLC Overlay Assay and IR-MALDI Mass Spectrometry. | Cancers (Basel) | 2026 | 41749917 | PubTator, text mining | PubMed |
| Application Effect of Colostrum Oral Immunotherapy in the Early Stage of Mechanical Ventilation for Very Low Birth Weight Preterm Infants. | J Multidiscip Healthc | 2026 | 41737366 | PubTator, text mining | PubMed |
| Chronic Ataxic Neuropathy With Disialosyl Antibodies Responsive to Zanubrutinib. | Eur J Neurol | 2026 | 41733016 | PubTator, text mining | PubMed |
| A case report of arsenic-induced peripheral neuropathy misdiagnosed as Guillain-Barré syndrome. | Front Toxicol | 2026 | 41717332 | PubTator, text mining | PubMed |
| Gangliosides GM3 And GD3 Modulate Insulin Aggregation Pathways and Reduce Cytotoxicity Through Structural Remodeling. | bioRxiv | 2026 | 41676560 | PubTator, text mining | PubMed |
| Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease. | Front Neurosci | 2026 | 41675236 | PubTator, text mining | PubMed |
| Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies. | Oncol Res | 2026 | 41613787 | PubTator, text mining | PubMed |
| The Cell-Specific Effects of the Human Remyelination-Promoting rHIgM22 on Sphingolipid Metabolism in Cultured Glial Cells. | Neurochem Res | 2026 | 41577839 | PubTator, text mining | PubMed |
| GM1 and GD3 Gangliosides Attenuate Diisopropylfluorophosphate-Induced NGF-TrkA and BDNF-TrkB Signaling Dysfunction. | ACS Chem Neurosci | 2026 | 41499342 | PubTator, text mining | PubMed |
| Overexpression of GM3 and Ganglioside Pattern Remodeling in Lung Adenocarcinoma Brain Metastases Identified by Ion Mobility Mass Spectrometry. | Int J Mol Sci | 2025 | 41465456 | PubTator, text mining | PubMed |
| Dynamic tracking of GD3 to GD2 gangliosides in T lymphoblasts via nuclear magnetic resonance spectroscopy. | Glycobiology | 2025 | 41395823 | PubTator, text mining | PubMed |
| Contemporary Synthetic Glycoscience: A Theme Issue Dedicated to the Memory of Hans Paulsen. | Molecules | 2025 | 41375216 | PubTator, text mining | PubMed |
| Transcriptomic signatures in Gaucher disease subtypes: A systems biology perspective. | Mol Genet Metab Rep | 2025 | 41323100 | PubTator, text mining | PubMed |
| Sphingolipids in Gaucher disease: a systematic review. | Orphanet J Rare Dis | 2025 | 41199336 | PubTator, text mining | PubMed |
| GD3 antibody subtyping reveals central-peripheral dichotomy in autoimmune neurological disorders. | J Neuroimmunol | 2025 | 41110350 | PubTator, text mining | PubMed |
| A Backwards Approach to GD2 Immunofluorescence in Human Neuroblastoma Tissue Samples: From Staining to Slicing. | Cells | 2025 | 41002426 | PubTator, text mining | PubMed |
| Engineering macrophages for targeted immunotherapy and drug delivery in melanoma. | J Transl Med | 2025 | 40993759 | PubTator, text mining | PubMed |
| Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma. | Int J Mol Sci | 2025 | 40943355 | PubTator, text mining | PubMed |
| Disruption of sphingolipid and glycosphingolipid profiles in human bronchial epithelial cells and extracellular vesicles during gradual benzo[a]pyrene-induced epithelial-to-mesenchymal transition. | Environ Res | 2025 | 40885511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/117189/papers?page=2